NASDAQ · Specialty Chemicals · USD
Linde plc (LIN) Stock Analysis
Linde plc (LIN) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
LIN Key Statistics
As of Oct 21, 2026Trading
- Open
- $497.25
- Previous Close
- $501.89
- Day's Range
- 496.68–502.18
- 52-Week Range
- 387.78–548.20
- Volume
- 1.40M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.71
Valuation
- Market Cap
- $230.75B
- P/E Ratio
- 32.32
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 25.57
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.95
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 6.51
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 15.49
Financials (FY)
- Revenue (FY)
- $33.99B+2.97%
- Net Income (FY)
- $6.90B+5.07%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 20.43%
- Shares Outstanding
- 460.98M
- 1-Year Return
- +12.73%
Dividend and dates
- Dividend
- $6.40+1.28%
- Ex-Dividend Date
- September 3, 2026
- Earnings Date
- October 29, 2026
- Avg Volume
- 2.08M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, LIN closed at $500.57, +12.73% over 1 year.
Linde plc (LIN) has a market capitalization of $230.75B.
In fiscal 2025, LIN reported revenue of $33.99B.
LIN Stock Return by Calendar Year
Linde plc (LIN) 10-year return: what $10,000 became
- 1 year
- $10,000 $11,273
- +12.73%
- 5 years
- $10,000 $17,205
- +72.05%
- 10 years
- $10,000 $49,268
- +392.68%
If you had invested $10,000 in Linde plc (LIN) 10 years ago, at the close on October 21, 2016, it would have been worth $49,268 at the close on October 21, 2026: +392.68% in total, +17.29% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +18.55% |
| 2025 | +3.22% |
| 2024 | +3.18% |
| 2023 | +27.66% |
| 2022 | −4.39% |
| 2021 | +33.39% |
| 2020 | +25.88% |
| 2019 | +39.04% |
| 2018 | +3.01% |
| 2017 | +35.14% |
| 2016 (partial year) | +1.24% |
As of October 21, 2026.
LIN Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $33.99B | $6.90B | 20.3% |
| 2024 | $33.01B | $6.57B | 19.9% |
| 2023 | $32.85B | $6.20B | 18.9% |
| 2022 | $33.36B | $4.15B | 12.4% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $33.99B | $16.60B | $9.25B | $6.90B | 20.3% |
| 2024 | $33.01B | $15.86B | $8.60B | $6.57B | 19.9% |
| 2023 | $32.85B | $15.36B | $8.11B | $6.20B | 18.9% |
| 2022 | $33.36B | $13.91B | $6.46B | $4.15B | 12.4% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
LIN Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $4.80 | 3 | — |
| 2025 | $6.00 | 4 | +7.9% |
| 2024 | $5.56 | 4 | +9.0% |
| 2023 | $5.10 | 4 | +9.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $4.80 | 3 | — |
| 2025 | $6.00 | 4 | +7.9% |
| 2024 | $5.56 | 4 | +9.0% |
| 2023 | $5.10 | 4 | +9.0% |
| 2022 | $4.68 | 4 | +10.4% |
| 2021 | $4.24 | 4 | +10.1% |
| 2020 | $3.85 | 4 | +10.1% |
| 2019 | $3.50 | 4 | +6.1% |
| 2018 | $3.30 | 4 | +4.7% |
| 2017 | $3.15 | 4 | +320.3% |
| 2016 | $0.75 | 1 | — |
Most recent payment: $1.60 per share, ex-dividend September 3, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
LIN Valuation vs Specialty Chemicals Median
Median of 70 stocks| Metric | LIN | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/E | 32.32 | 28.29 | 14% above |
| P/S ratio | 6.51 | 1.59 | 4.1x the median |
| Profit margin | 20.43% | 2.70% | 17.7 pts above |
Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Linde Expands Supply of Industrial Gases to Tata Steel in India
YahooRBC Capital Maintains Outperform on Linde, Lowers Price Target to $549
BenzingaLinde’s Quarterly Earnings Preview: What You Need to Know
BarchartLinde (LIN) Stock Looks Fully Valued On Current Earnings
YahooLinde plc (LIN) Adds Exposure to Industrial Gases and Secular Growth Trends
YahooLinde Is Powering the AI Revolution: Chart of the Day
Yahoo
All 20 articles ↓Show fewer ↑
Barclays Initiates Coverage On Linde with Overweight Rating, Announces Price Target of $577
BenzingaHere's How Much $100 Invested In Linde 10 Years Ago Would Be Worth Today
BenzingaCitigroup Maintains Buy on Linde, Lowers Price Target to $560
BenzingaAI Chip Demand Gives Linde a New Growth Catalyst
MarketBeatUBS Maintains Buy on Linde, Lowers Price Target to $574
BenzingaLinde Announces Third Quarter 2026 Earnings and Conference Call Schedule
YahooWhat is Linde’s (LIN) Economic Moat, and is it Widening or Narrowing?
YahooHere’s How Much You Would Have Made Owning Linde Stock In The Last 20 Years
BenzingaArgus Research Maintains Buy on Linde, Lowers Price Target to $538
BenzingaLinde Has Quietly Compounded for Years. These 3 Stocks Share Its Stickiest Advantage
24/7 Wall St.Linde (LIN) Draws Valuation Attention, Is The Premium Already Too Rich?
YahooThe Zacks Analyst Blog Highlights AMD, Linde, Amgen and INNOVATE
YahooTop Research Reports for AMD, Linde & Amgen
YahooKeybanc Initiates Coverage On Linde with Overweight Rating, Announces Price Target of $542
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Specialty Chemicals Stocks
The Sherwin-Williams Company
$81.88B
ECLEcolab Inc.
$80.76B
APDAir Products and Chemicals, Inc.
$67.40B
PPGPPG Industries, Inc.
$24.49B
IFFInternational Flavors & Fragrances Inc.
$23.23B
LYBLyondellBasell Industries N.V.
$20.44B
Popular Basic Materials Stocks
BHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B
FCXFreeport-McMoRan Inc.
$98.94B














